Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−5.64USD
−4.00 MUSD
1.98 M
About MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT)
Sector
Headquarters
Baltimore
Employees (FY)
6
Website
Founded
1989
FIGI
BBG0100RPY42
MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. It focuses on developing and commercializing the MyMD-1 and SUPERA-CBD therapeutic platforms. MyMD-1 is a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune diseases. Supera-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in Baltimore, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0A8D is 2.56 USD — it has increased by 0.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) stocks are traded under the ticker 0A8D.
MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) is going to release the next earnings report on May 20, 2024. Keep track of upcoming events with our Earnings Calendar.
0A8D stock is 0.11% volatile and has beta coefficient of −0.62. Check out the list of the most volatile stocks — is MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) there?
Yes, you can track MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
0A8D stock has risen by 19.76% compared to the previous week, the month change is a 2.77% rise, over the last year MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) has showed a 95.02% decrease.
0A8D net income for the last quarter is −2.36 M USD, while the quarter before that showed 4.04 M USD of net income which accounts for −158.46% change. Track more MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) financial stats to get the full picture.
Today MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) has the market capitalization of 6.17 M, it has increased by 22.86% over the last week.
No, 0A8D doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0A8D shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 6.00 employees. See our rating of the largest employees — is MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) stock shows the sell signal. See more of MYMD PHARMACEUTICALS INC COM NPV (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.